KEAP1 and Miyoshi myopathy: Collectively, these results indicate that MALAT1 cooperates with EZH2 to repress KEAP1 transcription, and suggest that MALAT1 inhibition may target the proteasome in MM cells by upregulating KEAP1, which negatively impacts NRF1 and NRF2 expression.